R-DXd showed a 50.5% objective response rate in platinum-resistant ovarian cancer, with a 5.6 mg/kg dose deemed optimal for further study. The safety profile was manageable, with 93.5% experiencing ...

Vanadiferous titanomagnetite (“VTM”) mineralization at Radar is comparable to global Fe–Ti–V systems such as Panzhihua (China ...

A home isn’t just made of walls and a roof; it’s built from memories, habits, and the everyday objects that fill its spaces.

Two nurses —Kyle Smith and Joanie Ippolito, who has since retired — founded Patches in 2000. Helping parents deal with the plight of their severely sick children —in some cases, with terminal ...

October 20, 2025- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. (CSPC) (Stock Code: 1093.HK) jointly announced that biparatopic HER2-targeting antibody-drug conjugate ...

Title: Biparatopic anti-HER2 antibody drug conjugate (ADC) JSKN003 in the treatment of primary platinum-refractory ovarian cancer (OC) Presentation Number: 1079P Onsite Poster display date: Saturday, ...

Robust CV5 lithium-only Feasibility Study ("FS") completed on the Shaakichiuwaanaan Project (Project) providing a defined ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new long-term data highlighting the sustained survival benefits of KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 ...

Amazon’s Prime Day is undoubtedly the retailer’s biggest sale, however, you’re most likely unaware of its Holiday Beauty ...

FDA-Registered Home Laser Technology Gains Rapid Adoption During Winter Season as Year-End HSA/FSA Deadlines Drive 290% Search Surge-Podiatrists Report Clinical-Grade Results Without $2,500+ Professio ...

Once that critical mineral is dug up, it will leave the Copper State entirely. Despite the six-decade project still not being ...